Parents in poor countries worry about vaccines, too | HHS advances development of new monoclonal antibody drug for Ebola | FDA to hire top lab safety official after report details gaps | Non-antibiotic drug shows promise in deadly C. difficile infections | Testing radiation detection systems in harsh conditions | Liberia struggles to regain economic footing after Ebola | When radiation isn’t the real risk | U.S. defense agencies dominate federal synthetic biology research | Enhanced airport entry screening to end for travelers from Liberia to U.S. | WHO panel changes 2 strains in Southern Hemisphere flu vaccine | Bird flu vaccine conditionally approved, but still can’t be sold | Asia’s biggest vaccine maker to seek fast-track nod for dengue drug in India | Iowa company gets first USDA-issued conditional license to develop bird flu vaccine | GAO finds National Biosurveillance Integration Center lacking | Ben Carson doesn’t get it: All our vaccines prevent death | WHO responds as Yemen as health facilities continue to shut down | FDA awards 18 grants to stimulate product development for rare diseases | New human virus discovered in old blood samples | Study adds to evidence that viruses are alive | After five years of delay, WMD plan is ‘nonsensical,’ critics say | Kansas City sees spike in Shigella infections | Big price increase for tuberculosis drug is rescinded | Refugees and migrants are more prone to foodborne diseases
See what we’re reading this week at Global Biodefense on topics including radiation detection systems, Shigella spike in the U.S., the bird flu vaccine and more…
Parents in poor countries worry about vaccines, too (NPR)
HHS advances development of new monoclonal antibody drug for Ebola (HHS)
FDA to hire top lab safety official after report details gaps (CIDRAP)
Non-antibiotic drug shows promise in deadly C. difficile infections (Reuters)
Testing radiation detection systems in harsh conditions (HSNW)
Liberia struggles to regain economic footing after Ebola (Reuters)
When radiation isn’t the real risk (NY Times)
U.S. defense agencies dominate federal synthetic biology research (HSNW)
Enhanced airport entry screening to end for travelers from Liberia to U.S. (CDC)
WHO panel changes 2 strains in Southern Hemisphere flu vaccine (CIDRAP)
Bird flu vaccine conditionally approved, but still can’t be sold (NY Times)
Asia’s biggest vaccine maker to seek fast-track nod for dengue drug in India (Reuters)
GAO finds National Biosurveillance Integration Center lacking (CIDRAP)
Ben Carson doesn’t get it: All our vaccines prevent death (Forbes)
WHO responds as Yemen as health facilities continue to shut down (WHO)
FDA awards 18 grants to stimulate product development for rare diseases (FDA)
New human virus discovered in old blood samples (Science)
Study adds to evidence that viruses are alive (EurekAlert)
After five years of delay, WMD plan is ‘nonsensical,’ critics say (Reuters)
Kansas City sees spike in Shigella infections (CNN)
Big price increase for tuberculosis drug is rescinded (NY Times)
Refugees and migrants are more prone to foodborne diseases (WHO)
